A case of concomitant pulmonary embolism and pulmonary tuberculosis in the era of COVID 19, a matter of cautious approach.
COVID 19
SARS‐ CoV‐2
anti‐coagulation
pulmonary embolism
pulmonary tuberculosis
thromboembolism
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
27
11
2020
accepted:
07
03
2021
entrez:
4
6
2021
pubmed:
5
6
2021
medline:
5
6
2021
Statut:
epublish
Résumé
Tuberculosis (TB) is known to the world for many years. It is associated with various complications and rarely with pulmonary embolism. However, due to its commonalities of presenting features with COVID 19, it can easily be missed and may be life threatening.
Identifiants
pubmed: 34084493
doi: 10.1002/ccr3.4071
pii: CCR34071
pmc: PMC8142413
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e04071Informations de copyright
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
All authors of this manuscript have no conflict of interest to declare.
Références
Pan Afr Med J. 2014 Apr 10;17:262
pubmed: 25309662
Thromb Res. 2010 May;125(5):478-80
pubmed: 20137804
Infect Chemother. 2019 Jun;51(2):142-149
pubmed: 31270993
BMJ Case Rep. 2019 Jun 2;12(6):
pubmed: 31160302
Infect Drug Resist. 2020 Jun 09;13:1663-1672
pubmed: 32606817
Natl Med J India. 2017 Jul-Aug;30(4):201-202
pubmed: 29162752
Lung India. 2017 Jan-Feb;34(1):65-69
pubmed: 28144063